Mike is currently a partner at Samsara BioCapital, where he has worked since March 2017. Prior to joining Samsara, Mike was a partner at New Leaf Venture Partners. Before New Leaf Venture Partners Mike was a principal at the Boston Consulting Group, where he consulted for biotech and pharma clients. Mike currently serves on the boards of directors of Nkarta (NKTX), Sutro (STRO), and several private companies, including EnaraBio, Fluent Biosciences, Respira Therapeutics and Ionpath. Mike received an AB in biochemical sciences from Harvard College and a PhD in molecular biology from University of California, Berkeley, where he was awarded a Howard Hughes Medical Institute fellowship.
Dybbs, Mike
Mike Dybbs, PhD
Partner, Samsara BioCapital
x
Mike Dybbs, PhD
Partner, Samsara BioCapital
Mike is currently a partner at Samsara BioCapital, where he has worked since March 2017. Prior to joining Samsara, Mike was a partner at New Leaf Venture Partners. Before New Leaf Venture Partners Mike was a principal at the Boston Consulting Group, where he consulted for biotech and pharma clients. Mike currently serves on the boards of directors of Nkarta (NKTX), Sutro (STRO), and several private companies, including EnaraBio, Fluent Biosciences, Respira Therapeutics and Ionpath. Mike received an AB in biochemical sciences from Harvard College and a PhD in molecular biology from University of California, Berkeley, where he was awarded a Howard Hughes Medical Institute fellowship.
